Cross-protection between group a and group b streptococci due to cross- reacting surface proteins

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 142-149

  Stålhammar Carlemalm, Margaretha ^a   Areschoug, Thomas ^a   Larsson, Charlotte ^a   Lindahl, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CROSS REACTION; DISEASE COURSE; IMMUNIZATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CROSS REACTIONS; DISEASE MODELS, ANIMAL; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PYOGENES; VACCINATION;

EID: 0033914316     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315693     Document Type: Article

References (41)

1. 1. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996;334:240-5.
2. 2. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: W.B. Saunders, 1995:980-1054.
3. 3. Fischetti VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 1989;2:285-314.
4. 4. Kehoe MA. Cell-wall associated proteins in gram-positive bacteria. N Compr Biochem 1994;27:217-61.
5. 5. Rubens CE, Wessels MR, Heggen LM, Kasper DL. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A 1987;84:7208-12.
6. 6. Wessels MR, Rubens CE, Benedi V-J, Kasper DL. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci U S A 1989;86:8983-7.
7. 7. Lancefield RC, Perlmann GE. Preparation and properties of a protein (R antigen) occurring in streptococci of group A, type 28 and in certain streptococci of other serological groups. J Exp Med 1952;96:83-97.
8. 8. Lancefield RC. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med 1957;106:525-14.
9. 9. Lancefield RC. Cellular antigens of group B streptococci. In: Wannamaker LW, Matsen JM, eds. Streptococci and Streptococcal diseases. New York: Academic Press, 1972:57-65.
10. 10. Stanley J, Linton D, Desai M, Efstratiou A, George R. Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease. J Clin Microbiol 1995;33:2850-5.
11. 11. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996;335:547-54.
12. 12. Mascini EM, Jansze M, Schellekens JFP, et al. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti exotoxin A antibodies. J Infect Dis 2000;181:631-8.
13. 13. Stälhammar-Carlemalm M, Areschoug T, Larsson C, Lindahl G. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol Microbiol 1999;33:208-19.
14. 14. Gilbert GL. Group A streptococci and puerperal fever. Med J Aust 1985; 143:271-2.
15. 15. Wilkinson HW. Comparison of streptococcal R antigens. Appl Microbiol 1972;24:669-70.
16. 16. Lancefield RC. Occurrence of R antigen specific for group A type 3 streptococci. J Exp Med 1958;108:329-41.
17. 17. Wiley GG, Bruno PN. Cross-reactions among group A streptococci. III. The M and R antigens of type 43 and serologically related streptococci. J Immunol 1970;105:1124-30.
18. 18. Flores AE, Ferrieri P. Molecular species of R-protein antigens produced by clinical isolates of group B streptococci. J Clin Microbiol 1989;27:1050-4.
19. 19. Stålhammar-Carlemalm M, Stenberg L, Lindahl G. Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med 1993;177:1593-603.
20. 20. Larsson C, Stålhammar-Carlemalm M, Lindahl G. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and α. Infect Immun 1996;64:3518-23.
21. 21. Larsson C, Stålhammar-Carlemalm M, Lindahl G. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine. Vaccine 1999;17:454-8.
22. 22. Wästfelt M, Stålhammar-Carlemalm M, Delisse AM, Cabezon T, Lindahl G. Identification of a family of streptococcal surface proteins with extremely repetitive structure. J Biol Chem 1996;271:18892-7.
23. 23. Michel JL, Madoff LC, Olson K, Kling DE, Kasper DL, Ausubel FM. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci U S A 1992;89:10060-4.
24. 24. Bevanger L, Naess AI. Mouse-protective antibodies against the Ibc proteins of group B streptococci. Acta Pathol Microbiol Immunol Scand B 1985;93: 121-4.
25. 25. Michel JL, Madoff LC, Kling DE, Kasper DL, Ausubel FM. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun 1991;59:2023-8.
26. 26. Lancefield RC. Type-specific polysaccharide antigens of group B streptococci. J Hyg Camb 1966;64:191-203.
27. 27. Akerström B, Brodin T, Reis K, Björck L. Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies. J Immunol 1985;135:2589-92.
28. 28. Young WW, Tamura Y, Wolock DM, Fox JW. Staphylococcal protein A binding to the Fab fragments of mouse monoclonal antibodies. J Immunol 1984;133:3163-6.
29. 29. Hedén LO, Frithz E, Lindahl G. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur J Immunol 1991;21:1481-90.
30. 30. Jerlström PG, Chhatwal GS, Timmis KN. The IgA-binding beta antigen of the c protein complex of group B streptococci: sequence determination of its gene and detection of two binding regions. Mol Microbiol 1991;5: 843-9.
31. 31. Kronvall G. A surface component in group A, C and G streptococci with non-immune reactivity for immunoglobulin G. J Immunol 1973;111: 1401-6.
32. 32. Stenberg L, O'Toole P, Lindahl G. Many group A streptococcal strains express two different immunoglobulin-binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M-type. Mol Microbiol 1992;6:1185-94.
33. 33. Areschoug T, Stålhammar-Carlemalm M, Larsson C, Lindahl G. Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V. Infect Immun 1999;67:6350-7.
34. 34. Russell-Jones GJ, Gotschlich EC. Identification of protein antigens of group B streptococci, with special reference to the Ibc antigens. J Exp Med 1984;160:1476-84.
35. 35. Guzman CA, Talay SR, Molinari G, Medina E, Chhatwal GS. Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein Sfb1. J Infect Dis 1999; 179:901-6.
36. 36. Dale JB, Chiang EY, Liu S, Courtney HS, Hasty DL. New protective antigen of group A streptococci. J Clin Invest 1999;103:1261-8.
37. 37. Fischer GW, Lowell GH, Crumrine MH, Bass JW. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera. J Exp Med 1978;148:776-86.
38. 38. Jennings HJ, Rosell K-G, Kasper DL. Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus. Can J Biochem 1980;58:112-20.
39. 39. Paoletti LC, Wessels MR, Rodewald AK, Shroff AA, Jennings HJ, Kasper DL. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1994;62:3236-43.
40. 40. Hougs L, Juul L, Ditzel HJ, Heilmann C, Svejgaard A, Barington T. The first dose of a Haemophilus influenzae type b conjugate vaccine reactivates memory B cells: evidence for extensive clonal selection, intraclonal affinity maturation, and multiple isotype switches to IgA2. J Immunol 1999;162: 224-37.
41. 41. Selin LK, Varga SV, Wong IC, Welsh RM. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med 1998;188:1705-15. The Journal of Infectious Diseases 2000;182:150-7